David P Brooks

David P Brooks

Johnson & Johnson Co. - New Jersey / United States
Business & Management / Business Administration
AD Scientific Index ID: 4394066
-
person_outline David P Brooks's MOST POPULAR ARTICLES
1-) N-((1S)-1-{[4-((2S)-2-{[(2, 4-dichlorophenyl) sulfonyl] amino}-3-hydroxypropanoyl)-1-piperazinyl] carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel …KS Thorneloe, AC Sulpizio, Z Lin, DJ Figueroa, AK Clouse, GP McCafferty, ...Journal of Pharmacology and Experimental Therapeutics 326 (2), 432-442, 20083742008
2-) Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestineJA Feild, L Zhang, KA Brun, DP Brooks, RM EdwardsBiochemical and biophysical research communications 258 (3), 578-582, 19992321999
3-) Antioxidant activity of carvedilol in cardiovascular diseaseP Dandona, H Ghanim, DP BrooksJournal of hypertension 25 (4), 731-741, 20072332007
4-) Pharmacology of synthetic organic selenium compoundsMJ Parnham, E Graf, VM Kolb, R Seth, S Sinha, RR Ruffolo, JP Hieble, ...Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des …, 19912321991
5-) Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-β type I receptor kinase in puromycin-induced nephritisET Grygielko, WM Martin, C Tweed, P Thornton, J Harling, DP Brooks, ...Journal of Pharmacology and Experimental Therapeutics 313 (3), 943-951, 20052262005